T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
SmartFinancial
SMBK
$899M
| $216K | ﹤0.01% |
+6,926
| New | +$230K |
|
2577
Universal Electronics
UEIC
$66.6M
| $216K | ﹤0.01% |
35,200
+10,200
| +41% | +$89.5K |
|
|
AGS
2578
DELISTED
PlayAGS
AGS
| $215K | ﹤0.01% |
17,677
+2,506
| +17% | +$30.1K |
|
|
FPI
2579
Farmland Partners
FPI
$425M
| $215K | ﹤0.01% |
19,234
+1,774
| +10% | +$20.4K |
|
2580
Arcturus Therapeutics
ARCT
$223M
| $214K | ﹤0.01% |
20,121
+1,103
| +6% | +$17.5K |
|
2581
Capital City Bank Group
CCBG
$898M
| $214K | ﹤0.01% |
+5,926
| New | +$215K |
|
2582
Cytek Biosciences
CTKB
$636M
| $214K | ﹤0.01% |
53,337
+6,148
| +13% | +$31.9K |
|
|
GDEN
2583
DELISTED
Golden Entertainment
GDEN
| $214K | ﹤0.01% |
8,075
+397
| +5% | +$12.2K |
|
2584
Westwood Holdings Group
WHG
$184M
| $214K | ﹤0.01% |
13,200
| – | – |
|
2585
Forum Energy Technologies
FET
$927M
| $213K | ﹤0.01% |
+10,557
| New | +$195K |
|
2586
Great Southern Bancorp
GSBC
$888M
| $213K | ﹤0.01% |
+3,837
| New | +$224K |
|
2587
Repay Holdings
RPAY
$317M
| $213K | ﹤0.01% |
38,068
+3,468
| +10% | +$23.9K |
|
2588
Rush Enterprises Class B
RUSHB
$9.37B
| $213K | ﹤0.01% |
+3,753
| New | +$209K |
|
|
SNBR
2589
DELISTED
Sleep Number
SNBR
| $213K | ﹤0.01% |
33,585
+1,023
| +3% | +$13.7K |
|
2590
Standard BioTools
LAB
$294M
| $212K | ﹤0.01% |
195,468
+14,000
| +8% | +$19.7K |
|
|
LOVE
2591
LoveSac
LOVE
$258M
| $212K | ﹤0.01% |
11,613
+151
| +1% | +$3.31K |
|
2592
Kura Oncology
KURA
$896M
| $210K | ﹤0.01% |
31,718
+3,648
| +13% | +$28.4K |
|
|
TERN
2593
DELISTED
Terns Pharmaceuticals
TERN
| $210K | ﹤0.01% |
76,052
-1,428,186
| -95% | -$5.83M |
|
2594
KULR Technology Group
KULR
$137M
| $209K | ﹤0.01% |
19,738
-2,800
| -12% | -$43.7K |
|
2595
Miller Industries
MLR
$640M
| $209K | ﹤0.01% |
4,926
+609
| +14% | +$35.4K |
|
2596
Canterbury Park Holding Corp
CPHC
$81.4M
| $208K | ﹤0.01% |
11,379
| – | – |
|
|
CTLP
2597
DELISTED
Cantaloupe
CTLP
| $208K | ﹤0.01% |
26,406
+4,123
| +19% | +$36.6K |
|
2598
Financial Institutions
FISI
$825M
| $207K | ﹤0.01% |
+8,259
| New | +$223K |
|
2599
Amylyx Pharmaceuticals
AMLX
$2.5B
| $205K | ﹤0.01% |
57,700
| – | – |
|
2600
CNB Financial Corp
CCNE
$1.04B
| $205K | ﹤0.01% |
+9,181
| New | +$223K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.